Farther Finance Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Farther Finance Advisors’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$257K	Buy	+3,645	New	+$222K	﹤0.01%	2100
2024 Q3	–	Sell	-1,000	Closed	-$41.6K	–	4050
2024 Q2	$41.6K	Sell	1,000 -174	-15%	-$7.27K	﹤0.01%	1497
2024 Q1	$53.4K	Buy	1,174 +174	+17%	+$7.93K	﹤0.01%	1164
2023 Q4	$46.2K	Hold	1,000	–	–	﹤0.01%	1060
2023 Q3	$40.7K	Buy	+1,000	New	+$45.5K	0.01%	836

Other funds holding GNOM

PFP

Polaris Financial Partners Westerville, Ohio $223M AUM

Armis Advisers Atlanta, Georgia $1.2B AUM 15.75% 1-Year Est. Return

Farther Finance Advisors's GNOM Position: Q3 2026 in Review

Farther Finance Advisors opened a new position in Global X Genomics & Biotechnology ETF (GNOM) in Q3 2026: 3,645 shares worth $257K. The stake represents ﹤0.01% of the portfolio and ranks #2100 among its holdings. This is a return to the name: Farther Finance Advisors previously reported a position in GNOM as recently as Q2 2024.

Farther Finance Advisors first reported a position in GNOM in Q3 2023 and has held it in 5 quarters since. 3 funds tracked by Wall St. Rank hold GNOM as of Q3 2026.

Farther Finance Advisors held 3,645 shares of Global X Genomics & Biotechnology ETF worth $257K as of Q3 2026.
Global X Genomics & Biotechnology ETF was a new Farther Finance Advisors position in Q3 2026.
Global X Genomics & Biotechnology ETF made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2100 holding.
Farther Finance Advisors first reported a position in Global X Genomics & Biotechnology ETF in Q3 2023 and has held it in 5 quarters since.
3 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.